Galina Selivanova Group - Our team

A presentation of the group members with contact information.

Group picture of Galina Selivanova group, picture taken outside
Galina Selivanova Group.

Group members

Galina Selivanova

Professor, research group leader
C1 Department of Microbiology, Tumor and Cell Biology

Sylvain Peuget

Assistant professor

Yue Zhan

External scholarship

xiaolei zhou

Affiliated to research

Gema Sanz Santos

Recent publications

Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization.
Aschtgen MS, Fragkoulis K, Sanz G, Normark S, Selivanova G, Henriques-Normark B, Peuget S
Oncogene 2022 Feb;():

p53-Dependent Repression: DREAM or Reality?
Peuget S, Selivanova G
Cancers (Basel) 2021 Sep;13(19):

Pharmacological activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting anti-tumor immunity.
Zhou X, Singh M, Sanz Santos G, Guerlavais V, Carvajal LA, Aivado M, Zhan Y, Oliveira MMS, Westerberg LS, Annis DA, Johnsen JI, Selivanova G
Cancer Discov 2021 Jul;():

Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin.
Guerrero-Garzón JF, Madland E, Zehl M, Singh M, Rezaei S, Aachmann FL, Courtade G, Urban E, Rückert C, Busche T, Kalinowski J, Cao YR, Jiang Y, Jiang CL, Selivanova G, Zotchev SB
iScience 2020 Dec;23(12):101785

Identification and targeting of selective vulnerability rendered by tamoxifen resistance.
Singh M, Zhou X, Chen X, Santos GS, Peuget S, Cheng Q, Rihani A, Arnér ESJ, Hartman J, Selivanova G
Breast Cancer Res 2020 07;22(1):80

p53 CRISPR Deletion Affects DNA Structure and Nuclear Architecture.
Rangel-Pozzo A, Booth S, Yu PLI, Singh M, Selivanova G, Mai S
J Clin Med 2020 Feb;9(2):

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds.
Peuget S, Zhu J, Sanz G, Singh M, Gaetani M, Chen X, Shi Y, Saei AA, Visnes T, Lindström MS, Rihani A, Moyano-Galceran L, Carlson JW, Hjerpe E, Joneborg U, Lehti K, Hartman J, Helleday T, Zubarev R, Selivanova G
Cancer Res 2020 04;80(7):1538-1550

Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes.
Zhu J, Singh M, Selivanova G, Peuget S
Sci Rep 2020 01;10(1):1049

RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
Ristau J, van Hoef V, Peuget S, Zhu J, Guan BJ, Liang S, Hatzoglou M, Topisirovic I, Selivanova G, Larsson O
Cell Death Dis 2019 11;10(11):845

Inhibition of p53 inhibitors: progress, challenges and perspectives.
Sanz G, Singh M, Peuget S, Selivanova G
J Mol Cell Biol 2019 07;11(7):586-599

Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia.
Demir S, Boldrin E, Sun Q, Hampp S, Tausch E, Eckert C, Ebinger M, Handgretinger R, Kronnie GT, Wiesmüller L, Stilgenbauer S, Selivanova G, Debatin KM, Meyer LH
Haematologica 2020 01;105(1):170-181

Contact and visit us

Contact information for the Galina Selivanova group at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.

Postal address

Karolinska Institutet
Department of Microbiology, Tumor and Cell Biology
171 77 Stockholm

Visiting address (visitors, couriers, etc.)

Karolinska Institutet
Biomedicum, Quarter C8
Solnavägen 9
171 65 Solna

Delivery address (goods, parcels, etc.)

Tomtebodavägen 16
1715 Solna

Where ot find us

Karolinska Institutet, Biomedicum, Solnavägen 9

Galina Selivanova

C1 Department of Microbiology, Tumor and Cell Biology